大象传媒

Home
Department of Clinical Medicine

News archive for Department of Clinical Medicine

The ethics, economics and ELSA research groups of CCBIO are coordinating聽their research activities ever more. In April they聽published their first聽joint book volume "Cancer Biomarkers: Ethics, Economics and Society".
Congratulations to Emilia Hugdahl for the YDF-award from the Norwegian Society of Dermatology and Venereology!
The Centre for Cancer Biomarkers CCBIO met for the 5th time at their Annual Symposium at Solstrand 19-20 April. "We wish to motivate, especially the younger researchers, to perform excellent cancer research," says Center Director Lars A. Akslen.
The regional health authorities' joint program for clinical therapy research (KLINBEFORSK) has February 27th 2017 allocated in total 124 million NOK to seven large research projects. The projects are closely linked to patient care and the requirements of the specialist health services. One of the supported projects is led by CCBIO PI Oddbj酶rn Straume, receiving 17,57 million NOK over five years.
Responsible cancer research should combine biomedical research activities with critical analysis of the same research, says CCBIO's Roger Strand and Lars A. Akslen in a recently published "perspectives" piece in the Norwegian medical journal "Tidsskriftet for Den norske legeforening".
The Norwegian Prime Minister Erna Solberg highlighted CCBIO PI James Lorens and his company BerGenBio in her New Year's Address as an example of excellent cancer research.
Andr茅 Sulen defended 09.12.16 his PhD dissertation "Leukocyte p38 and p53 proteins after environmental exposure; variation, associations and applicability" at the University of Bergen.
This semester鈥檚 last CCBIO Junior Scientist Symposium took place December 8th. More than 40 researchers participated at the seminar where Professor Arild Raaheim from the Department of Education, University of Bergen, started the day with the lecture 鈥淪upervision. Challenges and possibilities鈥.
Close to a billion NOK is distributed through Fripro funding this year, among other to young researchers and as mobility grants. Cancer researcher and CCBIO postdoc Agnete Engelsen at the Department of Biomedicine is one of the supported young talents.
Cornelia Schuster defended 22.11.2016 her dissertation "Investigation of predictive markers in patients with metastatic melanoma treated with bevacizumab" at the University of Bergen.
Lavina Ahmed defended Wednesday November 2nd 2016 her dissertation 芦Axl as a Biomarker in Breast and Lung Cancer禄 at the University of Bergen.
G酶ril Knutsvik defended Monday October 31st 2016 her thesis 鈥滲iomarkers in breast cancer, with special focus on tumor cell proliferation鈥 for the PhD degree at the University of Bergen.
Caroline Engen is a CCBIO PhD candidate who presented at the S.Net conference in Bergen. Her lecture was titled "Why Targeted Therapy May Not Work", and was part of the CCBIO session "The Transition from a Blockbuster Model to Personalised Cancer Therapy". We asked Caroline to walk us through a medical researcher's perspective of the conference and the use of new technologies.
CCBIO organized a special session with focus on the transition from a blockbuster to personalised cancer therapy at the S.Net conference recently held in Bergen.
11th October, CCBIO hosted a pre-conference event on the Ethical and Social Aspects of Cancer Research as part of the S.Net conference, of the Society for the Study of New and Emerging Technologies.
Medical research student (Forskerlinjestudent) Amalie A. Svan酶e was awarded with 3rd best oral presentation at joint International Congress of the International Academy of Pathology and the European Congress of Pathology, which took place in Cologne, Germany, September 25-29, 2016.

Pages